prikaz prve stranice dokumenta Comprehensive cardiac evaluation reveals no increase in ventricular arrhythmias in patients on chronic ibrutinib therapy: a study of KroHem, the Croatian cooperative group for hematologic diseases
  Download
PDF 846.32 KB
Conference presentation
Comprehensive cardiac evaluation reveals no increase in ventricular arrhythmias in patients on chronic ibrutinib therapy: a study of KroHem, the Croatian cooperative group for hematologic diseases
At: 26th Congress of the European Hematology Association. Online, Netherlands, 2021. https://doi.org/10.1097/HS9.0000000000000566
Kolačević Zeljković, Mateja; Bulj, Nikola; Bašić-Kinda, Sandra; Milunović, Vibor; Čaržavec, Dubravka; Jakšić, Ozren; Vodanović, Marijo; Ostojić-Kolonić, Slobodanka; Gaćina, Petar; Dujmović, D; Željković, Ivan; Pejša, Vlatko; Aurer, Igor

Cite this document

Kolačević Zeljković, M., Bulj, N., Bašić Kinda, S., Milunović, V., Čaržavec, D., Jakšić, O. ... Aurer, I. Comprehensive cardiac evaluation reveals no increase in ventricular arrhythmias in patients on chronic ibrutinib therapy: a study of KroHem, the Croatian cooperative group for hematologic diseases [PowerPoint slides]. Retrieved from https://urn.nsk.hr/urn:nbn:hr:220:516465

Kolačević Zeljković, Mateja, et al. "Comprehensive cardiac evaluation reveals no increase in ventricular arrhythmias in patients on chronic ibrutinib therapy: a study of KroHem, the Croatian cooperative group for hematologic diseases." 26th Congress of the European Hematology Association, 09.06.2021.-17.06.2021., Online, Netherlands. Presentation. https://urn.nsk.hr/urn:nbn:hr:220:516465

Kolačević Zeljković, Mateja, Nikola Bulj, Sandra Bašić Kinda, Vibor Milunović, Dubravka Čaržavec, Ozren Jakšić, Marijo Vodanović, et al. "Comprehensive cardiac evaluation reveals no increase in ventricular arrhythmias in patients on chronic ibrutinib therapy: a study of KroHem, the Croatian cooperative group for hematologic diseases." Presentation at 26th Congress of the European Hematology Association, Online, Netherlands, 09.06.2021.-17.06.2021. https://urn.nsk.hr/urn:nbn:hr:220:516465

Kolačević Zeljković, M., et al. 'Comprehensive cardiac evaluation reveals no increase in ventricular arrhythmias in patients on chronic ibrutinib therapy: a study of KroHem, the Croatian cooperative group for hematologic diseases' [Presentation], 26th Congress of the European Hematology Association. 09.06.2021.-17.06.2021. Available at: https://urn.nsk.hr/urn:nbn:hr:220:516465

Kolačević Zeljković M, Bulj N, Bašić Kinda S, Milunović V, Čaržavec D, Jakšić O, and sur.. Comprehensive cardiac evaluation reveals no increase in ventricular arrhythmias in patients on chronic ibrutinib therapy: a study of KroHem, the Croatian cooperative group for hematologic diseases. [Presentation] [cited 2024 November 18] Available at: https://urn.nsk.hr/urn:nbn:hr:220:516465

M. Kolačević Zeljković, et al., "Comprehensive cardiac evaluation reveals no increase in ventricular arrhythmias in patients on chronic ibrutinib therapy: a study of KroHem, the Croatian cooperative group for hematologic diseases", presented at: 26th Congress of the European Hematology Association, Online, 09.06.2021.-17.06.2021. Available at: https://urn.nsk.hr/urn:nbn:hr:220:516465

Please login to the repository to save this object to your list.
Metadata
Title (english)Comprehensive cardiac evaluation reveals no increase in ventricular arrhythmias in patients on chronic ibrutinib therapy: a study of KroHem, the Croatian cooperative group for hematologic diseases
AuthorMateja Kolačević Zeljković
AuthorNikola Bulj
AuthorSandra Bašić-Kinda
AuthorVibor Milunović
AuthorDubravka Čaržavec
AuthorOzren Jakšić
AuthorMarijo Vodanović
AuthorSlobodanka Ostojić-Kolonić
AuthorPetar Gaćina
AuthorD Dujmović
AuthorIvan Željković
AuthorVlatko Pejša
AuthorIgor Aurer
Author's institution(Sestre milosrdnice University Hospital Center)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Internal Medicine
Abstract (english)
Prolonged treatment with ibrutinib had no significant impact on number of VPBs or SPBs. Our study suggests that ibrutinib does not significantly increase the propensity to develop dangerous cardiac arrhythmias in patients who do not have clinically important structural heart disease or arrhythmias prior to treatment start and stresses the importance of hypertension control in this group of patients.
Languageenglish
Peer reviewPeer review - international
DOIhttps://doi.org/10.1097/HS9.0000000000000566
URN:NBNurn:nbn:hr:220:516465
Presentation date2021-08-31
ConferenceTitle: 26th Congress of the European Hematology Association
Acronym: EHA 2021
Location: Online, Netherlands
Organizer: European Hematology Association
Start date: 2021-06-09
End date: 2021-06-17
Assembly type: Lecture
Document URLhttps://journals.lww.com/hemasphere/Citation/2021/06002/EHA2021_Virtual_Congress_Abstract_Book.1.aspx
Type of resourceText
Access conditionsOpen access
Terms of useLicence Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) icon
Created on2022-08-31 11:45:45